PortfoliosLab logo

ProShares UltraShort Nasdaq Biotechnology (BIS)

ETF · Currency in USD
ISIN
US74347B7890
CUSIP
74347G838
Issuer
ProShares
Inception Date
Apr 7, 2010
Region
North America (U.S.)
Category
Leveraged Equities
Leveraged
2x
Expense Ratio
0.95%
Index Tracked
NASDAQ Biotechnology Index (-200%)
ETF Home Page
www.proshares.com
Asset Class
Equity

Asset Class Size

Multi-Cap

Asset Class Style

Growth

BISPrice Chart


Chart placeholderClick Calculate to get results

BISPerformance

The chart shows the growth of $10,000 invested in ProShares UltraShort Nasdaq Biotechnology on Apr 9, 2010 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $52 for a total return of roughly -99.48%. All prices are adjusted for splits and dividends.


BIS (ProShares UltraShort Nasdaq Biotechnology)
Benchmark (S&P 500)

BISReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
YTD23.57%-3.97%
1M27.64%-0.94%
6M30.88%7.48%
1Y20.63%21.47%
5Y-27.59%15.05%
10Y-36.31%12.63%

BISMonthly Returns Heatmap


Chart placeholderClick Calculate to get results

BISSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current ProShares UltraShort Nasdaq Biotechnology Sharpe ratio is 0.13. A Sharpe ratio between 0 and 1.0 is considered sub-optimal.

The chart below displays rolling 12-month Sharpe Ratio.


BIS (ProShares UltraShort Nasdaq Biotechnology)
Benchmark (S&P 500)

BISDividends

ProShares UltraShort Nasdaq Biotechnology granted a 0.00% dividend yield in the last twelve months, as of Jan 19, 2022. The annual payout for that period amounted to $0.00 per share.


PeriodTTM202120202019201820172016201520142013201220112010
Dividend$0.00$0.00$0.10$1.13$0.34$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00

Dividend yield

0.00%0.00%0.44%2.11%0.38%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

BISDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


BIS (ProShares UltraShort Nasdaq Biotechnology)
Benchmark (S&P 500)

BISWorst Drawdowns

The table below shows the maximum drawdowns of the ProShares UltraShort Nasdaq Biotechnology. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the ProShares UltraShort Nasdaq Biotechnology is 99.76%, recorded on Sep 2, 2021. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-99.76%Jul 7, 20102717Sep 2, 2021
-13.04%Jun 10, 20103Jun 15, 20109Jul 1, 201012
-11.83%May 7, 20104May 12, 20105May 20, 20109
-9.45%May 27, 20104Jun 3, 20102Jun 8, 20106
-6.59%Apr 28, 20102Apr 29, 20104May 5, 20106
-2.89%Apr 9, 20105Apr 15, 20104Apr 21, 20109
-1.87%Apr 23, 20101Apr 23, 20102Apr 27, 20103
-1.43%Jul 2, 20101Jul 2, 20101Jul 6, 20102

BISVolatility Chart

Current ProShares UltraShort Nasdaq Biotechnology volatility is 60.56%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


BIS (ProShares UltraShort Nasdaq Biotechnology)
Benchmark (S&P 500)

Portfolios with ProShares UltraShort Nasdaq Biotechnology


Loading data...

More Tools for ProShares UltraShort Nasdaq Biotechnology